Cargando…
Parents' dilemma: A therapeutic decision for children with spinal muscular atrophy (SMA) type 1
BACKGROUND: SMA type 1 is a severe neurodegenerative disorder that, in the absence of curative treatment, leads to death before 1 year of age without ventilatory support. Three innovative therapies are available to increase life expectancy. PURPOSE: (i) To increase knowledge about parents' expe...
Autores principales: | Boursange, Sophie, Araneda, Marco, Stalens, Caroline, Desguerre, Isabelle, Barnerias, Christine, Nougues, Marie-Christine, Isapof, Arnaud, Quijano-Roy, Susana, Blu Genestine, Nadia, Ouillade, Laetitia, Martinez Jalilie, Maripaz, Castiglioni, Claudia, Boespflug-Tanguy, Odile, Gargiulo, Marcela |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9811815/ https://www.ncbi.nlm.nih.gov/pubmed/36619514 http://dx.doi.org/10.3389/fped.2022.1062390 |
Ejemplares similares
-
Palliative Care in SMA Type 1: A Prospective Multicenter French Study Based on Parents' Reports
por: Hully, Marie, et al.
Publicado: (2020) -
Effects of nusinersen after one year of treatment in 123 children with SMA type 1 or 2: a French real-life observational study
por: Audic, Frédérique, et al.
Publicado: (2020) -
Improving Care and Empowering Adults Living with SMA: A Call to Action in the New Treatment Era
por: Walter, Maggie C., et al.
Publicado: (2021) -
CSF N-Glycan Profiles to Investigate Biomarkers in Brain Developmental Disorders: Application to Leukodystrophies Related to eIF2B Mutations
por: Fogli, Anne, et al.
Publicado: (2012) -
Evaluation of the endoplasmic reticulum-stress response in eIF2B-mutated lymphocytes and lymphoblasts from CACH/VWM patients
por: Horzinski, Laetitia, et al.
Publicado: (2010)